Publication | Closed Access
The Ruthenium Complex cis-(Dichloro)tetraammineruthenium(III) Chloride Presents Selective Cytotoxicity Against Murine B Cell Lymphoma (A-20), Murine Ascitic Sarcoma 180 (S-180), Human Breast Adenocarcinoma (SK-BR-3), and Human T Cell Leukemia (Jurkat) Tumor Cell Lines
20
Citations
39
References
2009
Year
Hematological MalignancyTumor BiologyLymphoid NeoplasiaOncologyMedicineImmunologyRuthenium Complex Cis-Tumor Cell LinesAnti-cancer AgentAdult T-cell Leukemia-lymphomaPharmacologyRadiation OncologyCancer ResearchHuman Breast Adenocarcinoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1